These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 32647325)

  • 1. Combining host-derived biomarkers with patient characteristics improves signature performance in predicting tuberculosis treatment outcomes.
    Sivakumaran D; Jenum S; Vaz M; Selvam S; Ottenhoff THM; Haks MC; Malherbe ST; Doherty TM; Ritz C; Grewal HMS
    Commun Biol; 2020 Jul; 3(1):359. PubMed ID: 32647325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host blood RNA signatures predict the outcome of tuberculosis treatment.
    Thompson EG; Du Y; Malherbe ST; Shankar S; Braun J; Valvo J; Ronacher K; Tromp G; Tabb DL; Alland D; Shenai S; Via LE; Warwick J; Aderem A; Scriba TJ; Winter J; Walzl G; Zak DE;
    Tuberculosis (Edinb); 2017 Dec; 107():48-58. PubMed ID: 29050771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of serum bradykinin and desArg
    Qian X; Nguyen DTM; Li Y; Lyu J; Graviss EA; Hu TY
    Tuberculosis (Edinb); 2016 Dec; 101S():S109-S118. PubMed ID: 27720377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host Blood RNA Transcript and Protein Signatures for Sputum-Independent Diagnostics of Tuberculosis in Adults.
    Sivakumaran D; Ritz C; Gjøen JE; Vaz M; Selvam S; Ottenhoff THM; Doherty TM; Jenum S; Grewal HMS
    Front Immunol; 2020; 11():626049. PubMed ID: 33613569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment Response.
    Warsinske HC; Rao AM; Moreira FMF; Santos PCP; Liu AB; Scott M; Malherbe ST; Ronacher K; Walzl G; Winter J; Sweeney TE; Croda J; Andrews JR; Khatri P
    JAMA Netw Open; 2018 Oct; 1(6):e183779. PubMed ID: 30646264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.
    Kurbatova EV; Gammino VM; Bayona J; Becerra MC; Danilovitz M; Falzon D; Gelmanova I; Keshavjee S; Leimane V; Mitnick CD; Quelapio MI; Riekstina V; Taylor A; Viiklepp P; Zignol M; Cegielski JP
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1335-43. PubMed ID: 23107633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine Kinetics in the First Week of Tuberculosis Therapy as a Tool to Confirm a Clinical Diagnosis and Guide Therapy.
    den Hertog AL; Montero-Martín M; Saunders RL; Blakiston M; Menting S; Sherchand JB; Lawson L; Oladimeji O; Abdurrahman ST; Cuevas LE; Anthony RM
    PLoS One; 2015; 10(6):e0129552. PubMed ID: 26115421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
    Kawasaki M; Echiverri C; Raymond L; Cadena E; Reside E; Gler MT; Oda T; Ito R; Higashiyama R; Katsuragi K; Liu Y
    PLoS Med; 2019 Apr; 16(4):e1002780. PubMed ID: 30978194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viable Mycobacterium tuberculosis in sputum after pulmonary tuberculosis cure.
    Ambreen A; Jamil M; Rahman MAU; Mustafa T
    BMC Infect Dis; 2019 Oct; 19(1):923. PubMed ID: 31666021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of nuclear factor, erythroid 2-like 2-mediated genes differentiates tuberculosis.
    Qian Z; Lv J; Kelly GT; Wang H; Zhang X; Gu W; Yin X; Wang T; Zhou T
    Tuberculosis (Edinb); 2016 Jul; 99():56-62. PubMed ID: 27450006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using simultaneous amplification and testing method for evaluating the treatment outcome of pulmonary tuberculosis.
    Yan L; Xiao H; Zhang Q
    BMC Infect Dis; 2018 Oct; 18(1):512. PubMed ID: 30309331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling the human immune response to Mycobacterium tuberculosis by human cytokine array.
    Chen T; Li Z; Yu L; Li H; Lin J; Guo H; Wang W; Chen L; Zhang X; Wang Y; Chen Y; Liao Q; Tan Y; Shu Y; Huang W; Cai C; Zhou Z; Yu M; Li G; Zhou L; Zhong Q; Bi L; Zhao M; Guo L; Zhou J
    Tuberculosis (Edinb); 2016 Mar; 97():108-17. PubMed ID: 26980502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Beclin-1 Expression in Human Alveolar Macrophage Significantly Correlate with the Bacteriologic Sterilization in Pulmonary Tuberculosis Patients.
    Yu Q; Zhu X; Di W; Jiang Y
    Clin Lab; 2016; 62(6):1003-7. PubMed ID: 27468561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel transcriptional signatures for sputum-independent diagnostics of tuberculosis in children.
    Gjøen JE; Jenum S; Sivakumaran D; Mukherjee A; Macaden R; Kabra SK; Lodha R; Ottenhoff THM; Haks MC; Doherty TM; Ritz C; Grewal HMS
    Sci Rep; 2017 Jul; 7(1):5839. PubMed ID: 28724962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electronic pillbox-enabled self-administered therapy versus standard directly observed therapy for tuberculosis medication adherence and treatment outcomes in Ethiopia (SELFTB): protocol for a multicenter randomized controlled trial.
    Manyazewal T; Woldeamanuel Y; Holland DP; Fekadu A; Blumberg HM; Marconi VC
    Trials; 2020 May; 21(1):383. PubMed ID: 32370774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.
    Holtz TH; Sternberg M; Kammerer S; Laserson KF; Riekstina V; Zarovska E; Skripconoka V; Wells CD; Leimane V
    Ann Intern Med; 2006 May; 144(9):650-9. PubMed ID: 16670134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking and 2-month culture conversion during anti-tuberculosis treatment.
    Maciel EL; Brioschi AP; Peres RL; Guidoni LM; Ribeiro FK; Hadad DJ; Vinhas SA; Zandonade E; Palaci M; Dietze R; Johnson JL
    Int J Tuberc Lung Dis; 2013 Feb; 17(2):225-8. PubMed ID: 23317958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with month 2 smear non-conversion among Category 1 tuberculosis patients in Karachi, Pakistan.
    D'Souza KA; Zaidi SMA; Jaswal M; Butt S; Khowaja S; Habib SS; Malik AA
    J Infect Public Health; 2018; 11(2):283-285. PubMed ID: 28662884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Outcome of Tuberculosis Patients under Directly Observed Treatment Short Course and Factors Affecting Outcome in Southern Ethiopia: A Five-Year Retrospective Study.
    Gebrezgabiher G; Romha G; Ejeta E; Asebe G; Zemene E; Ameni G
    PLoS One; 2016; 11(2):e0150560. PubMed ID: 26918458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
    Tiwari S; Kumar A; Kapoor SK
    Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.